Orgenesis Inc.
ORGS
Rank in Stocks
#33741
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell... Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.
Share Price
$0.35
Last synced: 2026-11-06
Market Cap
$16.50M
Change (1 day)
-12.50%
Change (1 year)
118.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Orgenesis Inc. (ORGS)
Category
Healthcare
EPS for Orgenesis Inc. (ORGS)
EPS as of September 2024 TTM: $-2.80
According to Orgenesis Inc.'s latest financial reports, its current EPS (TTM) is $-2.80. At the end of 2023 the company had an EPS of $-1.91, a decrease compared to its 2022 EPS of $-0.59.
EPS history for Orgenesis Inc. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.80 | 46.60% |
| 2023 | $-1.91 | 223.73% |
| 2022 | $-0.59 | -20.27% |
| 2021 | $-0.74 | -83.41% |
| 2020 | $-4.46 | 171.95% |
| 2019 | $-1.64 | 19.71% |
| 2018 | $-1.37 | 7.03% |
| 2017 | $-1.28 | 18.52% |
| 2016 | $-1.08 | 12.50% |
| 2015 | $-0.96 | -21.31% |
| 2014 | $-1.22 | -7.58% |
| 2013 | $-1.32 | 18.92% |
| 2012 | $-1.11 | 10,177.78% |
| 2011 | $-0.01 | 100.00% |
| 2010 | $-0.01 | 42.11% |
| 2009 | 0.00 | 660.00% |
| 2008 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -659.29% |
US
|
|
| $-7.07 | 152.50% |
US
|
|
| $-5.29 | 88.93% |
AU
|
|
| $12.88 | -560.00% |
BE
|
|
| $21.56 | -870.00% |
NL
|
Questions about Orgenesis Inc.'s earnings per share (EPS)
What is Orgenesis Inc.'s earnings per share (EPS)?
Orgenesis Inc.'s earnings per share (EPS) over the last twelve months is $-2.80, as of Sep 2024.
What was Orgenesis Inc.'s earnings per share (EPS) in 2023?
In 2023, Orgenesis Inc.'s earnings per share (EPS) was $-1.91, compared with $-0.59 in 2022.
How has Orgenesis Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Orgenesis Inc.'s earnings per share (EPS) was highest in 2022 ($-0.59) and lowest in 2020 ($-4.46).
How does Orgenesis Inc.'s earnings per share (EPS) compare with similar companies?
Orgenesis Inc.'s earnings per share (EPS) ($-2.80) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.